BrainMap

Iulia Alexandra Rus

- UNIVERSITATEA DE MEDICINA SI FARMACIE "IULIU HATIEGANU"

Researcher | Teaching staff | PhD student

Expertise & keywords

Wearable electrochemical sensors for the non-invasive detection of inflammatory mediators expressed in post-COVID-19 condition Call name: P 1 - SP 1.1 - Proiecte de cercetare pentru stimularea tinerelor echipe independente - TE-2021
PN-III-P1-1.1-TE-2021-1543 2022 - 2024

Role in this project:

Coordinating institution: UNIVERSITATEA DE MEDICINA SI FARMACIE "IULIU HATIEGANU"

Project partners: UNIVERSITATEA DE MEDICINA SI FARMACIE "IULIU HATIEGANU" (RO)

Affiliation:

Project website: https://wear-4-postcovaid.wixsite.com/wearable

Abstract:

Post-COVID-19 condition is characterized by a wide range of symptoms that may last more than 24 weeks after the onset of the infection, with high socio-economic impact. According to WHO, research on predictors for post-COVID-19 condition is of paramount importance to provide new strategies for minimizing SARS-CoV-2 post-infection consequences. The theme of WEAR-4-postCOVaID is very important, aiming for the validation of a panel of different types of biomarkers: interleukin 6, tumour necrosis factor-α, cortisol and kynurenic acid that can be used to early predict medical complications and to monitor patients’ rehabilitation after SARS-CoV-2 infection. The purpose of WEAR-4-postCOVaID is to develop a device for the rapid detection of biomarkers expressed in post-COVID-19 syndrome as a tool for medical staff for easier diagnosis and monitoring of patients. Deepening the knowledge about post-COVID-19 condition (1) and finding the interconnection between biomarkers levels in different body fluids and the main symptoms of this medical condition (2) are the goals of the project with specific and interconnected objectives. The originality of the project consists in the elaboration of innovative electrochemical sensors for the salivary detection of the four biomarkers, the correlation between the levels of the biomarkers (IL-6 and cortisol) in saliva and sweat, and the development of a dual wearable sensor for monitoring their levels in sweat with biomedical applications.

High accuracy innovative approach for the robotic assisted intraoperatory treatment of hepatic tumors based on imagistic-molecular diagnosis Call name: P 1 - SP 1.2 - Proiecte complexe realizate in consorții CDI
PN-III-P1-1.2-PCCDI-2017-0221 2018 - 2021

Role in this project:

Coordinating institution: UNIVERSITATEA TEHNICA DIN CLUJ - NAPOCA

Project partners: UNIVERSITATEA TEHNICA DIN CLUJ - NAPOCA (RO); UNIVERSITATEA DE MEDICINA SI FARMACIE "IULIU HATIEGANU" (RO); INSTITUTUL DE MECANICA SOLIDELOR (RO); INSTITUTUL REGIONAL DE GASTROENTEROLOGIE - HEPATOLOGIE PROF. DR. OCTAVIAN FODOR CLUJ-NAPOCA (RO); INSTITUTUL NATIONAL DE CERCETARE-DEZVOLTARE PENTRU OPTOELECTRONICA INOE 2000 INCD (RO)

Affiliation: UNIVERSITATEA DE MEDICINA SI FARMACIE "IULIU HATIEGANU" (RO)

Project website: https://cester.utcluj.ro/improve/home

Abstract:

The IMPROVE project will be developed by a transdisciplinary group, which integrates the knowledge of multiple specialists from the technical field (such as mechanical engineers, computer science engineers and material sciences engineers), a team of medical doctors (surgeons, gastroenterologists, oncologists, and radiologists), and a team of chemical scientists. The IMPROVE group will develop an innovative solution for the treatment of the patients diagnosed with non resectable hepatic tumors, based on a novel robotic system, and an novel medical imaging diagnostic tool. The majority of the hepatic tumors are not resectable due to a variety of factors such as tumor placement, size, and the patient general condition. In order to deliver a better palliative care towards the patient, and a better quality of life, the IMPROVE project proposes an integrated system to deliver treatment in the form of brachytherapy or chemotherapy. The treatment will be delivered in a minimally invasive manner, guided by a robot (which delivers the treatment agent through needles), based with a non-invasive diagnostic method. The diagnosis stage consists of the development of “smart” image analysis algorithms which can detect and define some hepatic diseases such as cancers. The preplanning stage will define the treatment method as well as the needle trajectories. For the treatment delivery a robotic structure will be developed to help the clinicians in the minimally invasive (laparoscopic) in situ procedure. The treatment agent (brachytherapy of chemotherapy) will be precisely delivered within the tumor using specialized instruments (for needle insertion and delivery) guided by the robotic system. The IMPROVE team is composed out of experienced researchers whit excellent results in the medical field, and well based former collaborations. The group synergy represents a key factor in obtaining positive results in the survival outcome of the hepatic cancer patients.

FILE DESCRIPTION	DOCUMENT
List of research grants as project coordinator or partner team leader
Significant R&D projects for enterprises, as project manager
R&D activities in enterprises
Peer-review activity for international programs/projects